ProQR Therapeutics N.V. Ordinary Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for PRQR, updated each market day.
PRQR AI Sentiment
AI sees no strong directional signal for ProQR Therapeutics N.V. Ordinary Shares stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About ProQR Therapeutics N.V. Ordinary Shares
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
Exchange
Market Cap
$208,614,906
Cap Tier
Employees
187
Listed Since
Sept. 18, 2014
Website
PRQR Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PRQR Volatility
ProQR Therapeutics N.V. Ordinary Shares has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
